On 6 May 2016, the Government published its response to ACIP’s review of designs law. Who knew? ACIP came up with 23 recommendations. For the most part, the Government accepted ACIP’s recommendations.
IP Australia issues consultation paper on ACIP’s report into the innovation patent system
ACIP’s final report into its review of the Designs System has been published. The report is 70 pages (including annexes) – 43 pages for the report itself; and 23 recommendations. Key recommendations include: investigate joining the Hague system and, if a decision is made to join, extend the maximum term of design protection to 15 years; introduce a grace period of 6 months before the filing date, but require an.. Read More
The Advisory Council on Intellectual Property (ACIP) has released an options paper for arising from its Review of the (Registered) Designs System.
ACIP’s final report into Innovation Patents has been published.
ACIP has published an issues paper reviewing the operation of the Designs Act 2003 for the first time since it came into force.
Nicholas J has ruled that Myriad’s patent for isolated gene sequences relating to BRCA1 are patentable subject matter for the purposes of Australia’s Patents Act 1990. Claim 1 of the Patent (No. 686004 entitled “In vivo mutations and polymorphisms in the 17q-linked breast and ovarian cancer susceptibility gene”) is for: An isolated nucleic acid coding for a mutant or polymorphic BRCA1 polypeptide, said nucleic acid containing in comparison to the BRCA1 polypeptide.. Read More
IP Australia is seeking comments on how the innovation patent system is working. Since 2001, Australia grants 2 types of patent: the standard patent with a normal term of 20 years and an innovation patent with a term up to 8 years. Ann innovation patent need show only an innovative step over the prior art to be valid. According to the Full Court in Delnorth, this requires a difference that.. Read More
The Senate’s Legal and Constitutional Affairs Committee has, by majority, recommended that the Senate should not pass the Patent Amendment (Human Genes and Biological Materials) Bill 2010. The Bill is a private members’ effort and, perhaps not surprisingly, the three of its sponsor still in the Senate dissented. (At the time of writing, it is proving difficult to get a working link to the text of the Bill itself.) According to.. Read More
On 28 February, the Minister directed ACIP to report on the innovation patent system. On 17 August, ACIP published an issues paper (pdf) and now seeks your comments by 14 October 2011. According to the announcement of the issue paper’s release: In recent years a variety of concerns have been raised about the innovation patent system and whether it is meeting its original objectives. A key concern is that an innovation.. Read More